Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polygeline.

M J Davies

    Developments in Biological Standardization
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Polygeline, a degraded gelatin derivative, is used for hypovolemia management. Recent preparation changes reduced adverse reactions to 0.78%.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency.

    Diabetes, obesity & metabolism·2008
    Same author

    Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.

    Diabetes, obesity & metabolism·2008
    Same author

    Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.

    Diabetologia·2008
    Same author

    Age influences the early events of skeletal muscle regeneration: studies of whole muscle grafts transplanted between young (8 weeks) and old (13-21 months) mice.

    Experimental gerontology·2008
    Same author

    The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro.

    British journal of cancer·2008
    Same author

    The DESMOND educational intervention.

    Chronic illness·2008
    Same journal

    International challenges and public policy issues.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in China.

    Developments in biological standardization·2000
    Same journal

    ICH activities on biotech topics.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in the European Union.

    Developments in biological standardization·2000
    Same journal

    Standardisation and licensing of combination vaccines based on DTP.

    Developments in biological standardization·2000
    Same journal

    Control of foot-and-mouth disease by vaccination.

    Developments in biological standardization·2000
    See all related articles

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Clinical Medicine

    Background:

    • Polygeline is a polymer derived from degraded gelatin, featuring a mean molecular weight of 35,000.
    • It is supplied as a 3.5% solution (Haemaccel) containing essential ions like sodium, potassium, calcium, and chloride.
    • Polygeline exhibits a short half-life of 3-6 hours, extending to 16 hours in renal impairment.

    Purpose of the Study:

    • To detail the properties and applications of polygeline in clinical settings.
    • To highlight its role in managing hypovolemia and associated limitations.
    • To report on adverse reactions and the impact of recent preparation modifications.

    Main Methods:

    • Characterization of polygeline's molecular weight and composition.
    • Analysis of its pharmacokinetic profile, including half-life variations.

    Related Experiment Videos

  • Review of clinical usage, dosage limits, and reported adverse events.

    • Main Results:

    • Polygeline is administered for hypovolemia, with adult dosage limited to approximately 1,500 ml due to hemodilution tolerance.
    • Histamine release, potentially causing hypotension, bronchospasm, and rash, has been documented.
    • Recent preparation improvements have decreased the incidence of adverse reactions to 0.78%.

    Conclusions:

    • Polygeline is an effective plasma volume expander for hypovolemia.
    • Awareness of potential histamine-mediated side effects is crucial.
    • Modified polygeline preparations offer an improved safety profile.